Cargando…

DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort

BACKGROUND: As dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) has been implicated in the abnormal hyperphosphorylation of tau in Alzheimer's disease (AD) brain, and the development of neurofibrillary tangles, we examined the contribution of this gene to the susceptibilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Higuera, José Luis, Sánchez-Juan, Pascual, Rodríguez-Rodríguez, Eloy, Mateo, Ignacio, Pozueta, Ana, Frank, Ana, Sastre, Isabel, Valdivieso, Fernando, Berciano, José, Bullido, María J, Combarros, Onofre
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797783/ https://www.ncbi.nlm.nih.gov/pubmed/19995442 http://dx.doi.org/10.1186/1471-2350-10-129

Ejemplares similares

Caspase-1 genetic variation is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2010)

Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José L, et al.
Publicado: (2011)

Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
por: Pozueta, Ana, et al.
Publicado: (2011)

No association of CDK5 genetic variants with Alzheimer's disease risk
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2009)

Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2019)

Evaluation of choroidal thickness in prodromal Alzheimer’s disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2020)

Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia
por: Lage, Carmen, et al.
Publicado: (2021)

Dyrk1 inhibition improves Alzheimer's disease‐like pathology
por: Branca, Caterina, et al.
Publicado: (2017)

Plasma DYRK1A as a novel risk factor for Alzheimer's disease
por: Janel, N, et al.
Publicado: (2014)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Blau Syndrome-Related CARD15/NOD2 Mutations Are Not Linked to Idiopathic Uveitis in Spanish Patients
por: Rodríguez-Pérez, Noelia, et al.
Publicado: (2009)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Herpes Simplex Virus Type 1 Induces AD-like Neurodegeneration Markers in Human Progenitor and Differentiated ReNcell VM Cells
por: Salgado, Blanca, et al.
Publicado: (2023)

Variability and associated factors in the management of cord clamping and the milking practice among Spanish obstetric professionals
por: Ortiz-Esquinas, Inmaculada, et al.
Publicado: (2020)

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
por: Janel, N, et al.
Publicado: (2017)

Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer’s Disease
por: Dowjat, Karol, et al.
Publicado: (2019)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
por: López-García, Sara, et al.
Publicado: (2021)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

The Spanish gut microbiome reveals links between microorganisms and Mediterranean diet
por: Latorre-Pérez, Adriel, et al.
Publicado: (2021)

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
por: Martínez-Dubarbie, Francisco, et al.
Publicado: (2023)

DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes
por: Zhu, Bangfu, et al.
Publicado: (2022)

Oxidative Stress Enhances Neurodegeneration Markers Induced by Herpes Simplex Virus Type 1 Infection in Human Neuroblastoma Cells
por: Santana, Soraya, et al.
Publicado: (2013)

Clinical course of epilepsy and white matter abnormality linked to a novel DYRK1A variant
por: Okazaki, Tetsuya, et al.
Publicado: (2021)

The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022)

Impaired macroglial development and axonal conductivity contributes to the neuropathology of DYRK1A-related intellectual disability syndrome
por: Pijuan, Isabel, et al.
Publicado: (2022)

Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity
por: Tu, Huang-Ju, et al.
Publicado: (2023)

Translation and Cultural Adaptation into Spanish of the Engagement in Meaningful Activities Survey
por: Judit, Fernández-Solano Ana, et al.
Publicado: (2022)

Calorimeters - ATLAS Fact Sheet [Spanish]
por: Rodriguez Vera, Ana Maria, et al.
Publicado: (2021)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
por: Rodríguez-Rubio, Enrique, et al.
Publicado: (2021)

Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum
por: Mendoza-Caamal, Elvia C., et al.
Publicado: (2021)

Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob Diseases
por: Calero, Olga, et al.
Publicado: (2011)

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
por: Demuro, Stefania, et al.
Publicado: (2021)

Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons()
por: Balibrea, Jose M., et al.
Publicado: (2020)

Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013)

Ocular Phenotype Associated with DYRK1A Variants
por: Méjécase, Cécile, et al.
Publicado: (2021)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

Functional Roles of DYRK2 as a Tumor Regulator
por: Mochimaru, Yuta, et al.
Publicado: (2023)

A novel de novo heterozygous DYRK1A mutation causes complete loss of DYRK1A function and developmental delay
por: Lee, Kyu-Sun, et al.
Publicado: (2020)

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_daeurgbev0tg7dmnvqu7vmu546